Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
Public health officials and private researchers have vowed to develop a coronavirus vaccine in record time. But could that rush backfire? Guest: Jan Hoffman, a health reporter for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily
Background reading:
- Billions of dollars are being poured into developing a coronavirus vaccine, but the rapid timetable may be creating even more vaccine-hesitant patients.
- Three vaccine developers report that early trials showed promising results with minimal side effects, but one researcher cautioned, “There is still a long way to go.”
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Thank you for listening to this episode of Daily News. We've gathered all the additional resources, book For more updates and exclusive content, visit our official site: ➡️ 🚨[VIP ACCESS]🚨
Subscribe and leave a review! ➡️ SUBSCRIBE
Copyright Disclaimer: We are not the official Daily news or Spotify feed. All rights to the original content belong to their respective owners. This channel is sustained through dynamic ad insertion to offset AI processing, hosting, and transcription costs.
Hosted on Acast. See acast.com/privacy for more information.
Jan Hoffman
nytimes.comnytimes.com/thedaily
nytimes.comcreating even more vaccine-hesitant patients
nytimes.comone researcher cautioned
nytimes.comnytimes.com/podcasts
nytimes.compcm.adswizz.com
pcm.adswizz.com[VIP ACCESS]
0ymbe1o.short.gyacast.com/privacy
acast.com